Processing
News
-
Integrated DNA Technologies Opens New Therapeutic Manufacturing Facility to Support Growing Demand in Genomic Medicine
-
Integrated DNA Technologies Reveals Launch of xGen™ Products for Ultima Genomics®
-
Integrated DNA Technologies and Aldevron® Activate Strategic Partnership to Deliver Key CRISPR Components to Cell and Gene Therapy Developers
-
Integrated DNA Technologies Launches New Respiratory Virus Panel
-
Integrated DNA Technologies Launches New Archer™ FUSIONPlex™ Core Solid Tumor Panel for Cancer Research
-
Integrated DNA Technologies Bolsters Leadership Team, Adds New Global Head of Commercial
-
Integrated DNA Technologies Debuts Collab Network
-
Integrated DNA Technologies Expands Access, Expedites Turnaround Time, for Minimal Residual Disease (MRD) Solutions for Cancer Research
-
Integrated DNA Technologies Acquires ArcherDX Next Generation Sequencing Research Assays from Invitae Corporation
-
PR Timing Test
-
Integrated DNA Technologies Launches New PrimeTime™ qPCR One-Step Master Mix with Exclusive Mutant Enzyme
-
Integrated DNA Technologies Expands Customization Options for Alt-R™ Custom CRISPR gRNA Libraries for Drug Discovery
-
Integrated DNA Technologies Launches Complete NGS Library Preparation Solution for Monkeypox
-
Integrated DNA Technologies, Beckman Coulter Life Sciences Ink Distribution Deal
-
Catalytic Data Science Joins Integrated DNA Technologies Align Program
-
Integrated DNA Technologies Adds MLL Munich Leukemia Laboratory to Align Program
-
IDT unveils new solution to accelerate homology-directed repair genome editing research
-
Demaris Mills Appointed President of IDT
-
Editas Medicine and IDT Announce Publication in Nature Communications of Research Data Supporting the Use of Optimized AsCas12a Nuclease Variant, Alt-R A.s. Cas12a (Cpf1) Ultra, in Researching the Potential of Gene-Edited Cell Medicines
-
Predicine Joins IDT Align Program
Media and PR
For media inquiries please contact IDT Public Relations, idtpr@idtdna.com